Enhabit Inc. (EHAB)
| Bid | 7.85 |
| Market Cap | 397.28M |
| Revenue (ttm) | 1.03B |
| Net Income (ttm) | -156.2M |
| EPS (ttm) | -3.11 |
| PE Ratio (ttm) | -2.53 |
| Forward PE | 17.1 |
| Analyst | Hold |
| Ask | 7.88 |
| Volume | 76,574 |
| Avg. Volume (20D) | 336,257 |
| Open | 7.84 |
| Previous Close | 7.78 |
| Day's Range | 7.83 - 7.94 |
| 52-Week Range | 6.85 - 10.70 |
| Beta | 1.19 |
About EHAB
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, P...
Analyst Forecast
According to 3 analyst ratings, the average rating for EHAB stock is "Hold." The 12-month stock price forecast is $8, which is an increase of 1.65% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · businesswire.com
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 GuidanceDALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024. “Enhabit is e...
2 months ago · businesswire.com
Enhabit Home Health & Hospice Announces Date of 2024 Fourth Quarter Earnings CallDALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2024, on Marc...